Recalls from Diagnostic Grifols, S.A.

• Diagnostic Grifols Erytra Analyzer (opens in a new tab)
  Moderate risk, FDA, Oct 9, 2026, Software defect
• Diagnostic Grifols Erytra and Erytra Eflexis Automated Blood Grouping and Antibody Test Systems (opens in a new tab)
  Low risk, FDA, Oct 7, 2026

Data: Recall Canary (opens in a new tab)